Is SKYE or SLGL more undervalued in 2026?

CirclFi compares Skye Bioscience, Inc. (SKYE) and Sol-Gel Technologies Ltd. (SLGL) using 13 institutional-grade valuation models. SKYE has a Quality of Company score of 3.6/10 while SLGL scores 2.1/10.

Which is a better buy — SKYE or SLGL?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do SKYE and SLGL valuations compare?

SKYE at $0.85 and SLGL at $75.28 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

SKYE vs SLGL Valuation Comparison 2026 — Intrinsic Value Analysis

SKYE

Biotechnology

Skye Bioscience, Inc.

Quality

3.6

out of 10

Value Trap

LOW

Price

$0.85

Last close

Models

7/13

Active

SLGL

Biotechnology

Sol-Gel Technologies Ltd.

Quality

2.1

out of 10

Value Trap

—

Price

$75.28

Last close

Models

10/13

Active

Model-by-Model Comparison

Model	Type	SKYE Fair Value	SKYE Upside	SLGL Fair Value	SLGL Upside
Bayesian DCF	Intrinsic	$0.21	-74.8%	$19.96	-73.5%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$1.84	+116.7%	$4.09	-94.5%
PWERM	Option-Based	$1.09	+27.7%	$47.09	-36.2%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%
RCMH-DCF	Intrinsic	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for SKYE vs SLGL — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

SKYE vs SLGL — Which Stock Is More Undervalued?

SKYE scores higher with a 3.6/10 quality rating vs SLGL's 2.1/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Skye Bioscience, Inc. (SKYE) and Sol-Gel Technologies Ltd. (SLGL) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

SKYE currently trades at $0.85 with a QOC of 3.6/10, while SLGL trades at $75.28 with a QOC of 2.1/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).